CC BY-NC-ND 4.0 · Journal of Gastrointestinal and Abdominal Radiology 2023; 06(01): 062-066
DOI: 10.1055/s-0042-1758122
Case Report

Rare Columnar Cell Variant Papillary Thyroid Carcinoma with Metastasis to Pancreas and Lungs at Initial Presentation: A Case Report and Review of Literature

Albert Gjeluci
1   Department of Radiology, Loyola University Medical Center, Maywood, Illinois, United States
,
2   Department of Medical Oncology, Loyola University Medical Center, Maywood, Illinois, United States
,
Anugayathri Jawahar
1   Department of Radiology, Loyola University Medical Center, Maywood, Illinois, United States
› Author Affiliations

Abstract

Papillary thyroid cancer (PTC) is the most common endocrine malignancy, accounting for 85% of differentiated thyroid cancers. A small percentage of PTC variants are considered more aggressive, such as the tall cell variant associated with the V600E mutation in the BRAF gene and the rarer columnar variant, which is described in only 0.2% of cases and has a poor prognosis. Although locoregional metastases to neck lymph nodes are common, distant metastases of PTC are rare at presentation with only 5 to 7% reported in the literature. We present a very rare case of columnar cell variant PTC with synchronous metastasis to the lungs and indolent focus in the pancreas at initial diagnosis, which has never been reported in the literature. Our patient presented with non-radioactive iodine (RAI) responsive PTC with diffuse metastases to the lungs and one synchronous focal metastatic lesion in the pancreas. After multidisciplinary discussions, pancreatectomy/metastasectomy was deferred due to the disseminated PTC with multiple metastases to the lungs, lack of pancreas-related symptoms in the patient, and inherent complication risks. The patient was treated with systemic therapy using a tyrosine kinase inhibitor (lenvatinib), which is the standard of care for non-RAI responsive PTC and showed a complete radiologic resolution of the pancreatic lesion, however, with partial yet nonprogressive metastatic disease in the lungs.

Note

This study received funding in the form of imaging equipment. The patient described in the manuscript was from the Department of Radiology, Loyola University Medical Center, Maywood, IL, USA. The pathology examination was from the Department of Pathology, Loyola University Medical Center, Maywood, IL, USA.




Publication History

Article published online:
30 December 2022

© 2022. Indian Society of Gastrointestinal and Abdominal Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Farina E, Monari F, Tallini G. et al. Unusual thyroid carcinoma metastases: a case series and literature review. Endocr Pathol 2016; 27 (01) 55-64
  • 2 Davidson M, Olsen RJ, Ewton AA, Robbins RJ. Pancreas metastases from papillary thyroid carcinoma: a review of the literature. Endocr Pract 2017; 23 (12) 1425-1429
  • 3 Rossi G, Petrone MC, Schiavo Lena M. et al. Pancreatic metastasis of papillary thyroid carcinoma with an intraductal growth pattern. Endoscopy 2020; 52 (12) E452-E453
  • 4 Song E, Jeon MJ, Oh HS. et al. Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classic papillary thyroid carcinoma?. Eur J Endocrinol 2018; 179 (03) 135-142
  • 5 Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994; 97 (05) 418-428
  • 6 Cho M, Acosta-Gonzalez G, Brandler TC, Basu A, Wei XJ, Simms A. Papillary thyroid carcinoma metastatic to the pancreas: case report. Diagn Cytopathol 2019; 47 (03) 214-217
  • 7 Cho J, Shin JH, Hahn SY, Oh YL. Columnar cell variant of papillary thyroid carcinoma: ultrasonographic and clinical differentiation between the indolent and aggressive types. Korean J Radiol 2018; 19 (05) 1000-1005
  • 8 Bongiovanni M, Mermod M, Canberk S. et al. Columnar cell variant of papillary thyroid carcinoma: cytomorphological characteristics of 11 cases with histological correlation and literature review. Cancer Cytopathol 2017; 125 (06) 389-397
  • 9 Ren H, Ke N, Tan C, Wang X, Cao W, Liu X. Unusual metastasis of papillary thyroid cancer to the pancreas, liver, and diaphragm: a case report with review of literature. BMC Surg 2020; 20 (01) 82
  • 10 Angeles-Angeles A, Chable-Montero F, Martinez-Benitez B, Albores-Saavedra J. Unusual metastases of papillary thyroid carcinoma: report of 2 cases. Ann Diagn Pathol 2009; 13 (03) 189-196
  • 11 Yoon JH, Jeon MJ, Kim M. et al. Unusual metastases from differentiated thyroid cancers: a multicenter study in Korea. PLoS One 2020; 15 (08) e0238207
  • 12 Chen L, Brainard JA. Pancreatic metastasis from papillary thyroid carcinoma diagnosed by endoscopic ultrasound-guided fine needle aspiration: a case report. Acta Cytol 2010; 54 (04) 640-644
  • 13 Tunio MA, Alasiri M, Riaz K, Alshakweer W. Pancreas as delayed site of metastasis from papillary thyroid carcinoma. Case Rep Gastrointest Med 2013; 2013: 386263
  • 14 Smith AL, Odronic SI, Springer BS, Reynolds JP. Solid tumor metastases to the pancreas diagnosed by FNA: a single-institution experience and review of the literature. Cancer Cytopathol 2015; 123 (06) 347-355
  • 15 Li XO, Li ZP, Wang P. et al. Pancreatic metastasis of papillary thyroid carcinoma: a case report with review of the literature. Int J Clin Exp Pathol 2014; 7 (02) 819-822